IP Verse

Method Of Treating Cancer Using Selective Estrogen Receptor Modulators

Patent No. EP3834824 (titled "Method Of Treating Cancer Using Selective Estrogen Receptor Modulators") was filed by Duke University on Mar 28, 2015. The application was issued on Oct 22, 2025.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKJul 21, 2026CROW
SYNTHONJul 20, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
TEVA PHARMACEUTICAL INDUSTRIES LTDJul 20, 2026VON KAUFFMANN
SANDOZJul 14, 2026ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3834824

DUKE UNIVERSITY
Application Number
EP21151737A
Filing Date
Mar 28, 2015
Status
Granted And Under Opposition
Sep 19, 2025
Publication Date
Oct 22, 2025
External Links
Slate, Register , Google Patents